Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2004 1
2007 1
2008 1
2012 1
2015 3
2016 3
2017 4
2018 9
2019 9
2020 6
2021 6
2022 4
2023 3
2024 4
2025 6
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis.
Maffioli M, Mora B, Ball S, Iurlo A, Elli EM, Finazzi MC, Polverelli N, Rumi E, Caramella M, Carraro MC, D'Adda M, Molteni A, Sissa C, Lunghi F, Vismara A, Ubezio M, Guidetti A, Caberlon S, Anghilieri M, Komrokji R, Cattaneo D, Della Porta MG, Giorgino T, Bertù L, Brociner M, Kuykendall A, Passamonti F. Maffioli M, et al. Among authors: d adda m. Blood Adv. 2022 Mar 22;6(6):1855-1864. doi: 10.1182/bloodadvances.2021006889. Blood Adv. 2022. PMID: 35130339 Free PMC article.
Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia: a randomized trial.
Mazzucconi MG, Rodeghiero F, Avvisati G, De Stefano V, Gugliotta L, Ruggeri M, Vianelli N, Fazi P, Paoloni F, Sargentini V, Baldacci E, Ferretti A, Martino B, Vincelli ID, Carli G, Fortuna S, Di Ianni M, Ranalli P, Palandri F, Polverelli N, Lugli E, Rivolti E, Patriarca A, Rago A, D'Adda M, Gentile M, Siragusa S, Sibilla S, Carella AM, Rossi E, Battistini R, Zaja F, Bocchia M, Di Renzo N, Musto P, Crugnola M, Giuffrida AC, Krampera M, Tafuri A, Santoro C. Mazzucconi MG, et al. Among authors: d adda m. Blood Adv. 2024 Mar 26;8(6):1529-1540. doi: 10.1182/bloodadvances.2023010975. Blood Adv. 2024. PMID: 38231017 Free PMC article. Clinical Trial.
Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a Position Paper on behalf of the Chronic Malignancies Working Party of the EBMT.
Polverelli N, Hernández-Boluda JC, Czerw T, Barbui T, D'Adda M, Deeg HJ, Ditschkowski M, Harrison C, Kröger NM, Mesa R, Passamonti F, Palandri F, Pemmaraju N, Popat U, Rondelli D, Vannucchi AM, Verstovsek S, Robin M, Colecchia A, Grazioli L, Damiani E, Russo D, Brady J, Patch D, Blamek S, Damaj GL, Hayden P, McLornan DP, Yakoub-Agha I. Polverelli N, et al. Among authors: d adda m. Lancet Haematol. 2023 Jan;10(1):e59-e70. doi: 10.1016/S2352-3026(22)00330-1. Epub 2022 Dec 6. Lancet Haematol. 2023. PMID: 36493799 Review.
The 2024 Three-Strata Baseline Anemia Definition of the Revised IWG-ELN Criteria Dissects Survival in Ruxolitinib-Treated Myelofibrosis Patients.
Maffioli M, Mora B, Iurlo A, Elli EM, Finazzi MC, Farina M, Rumi E, Caramella M, Carraro MC, D'Adda M, Molteni A, Mimiola E, Lunghi F, Vismara A, Ubezio M, Di Chio MC, Anghilieri M, Cattaneo D, Della Porta MG, Bertù L, Coscia M, Passamonti F. Maffioli M, et al. Among authors: d adda m. Am J Hematol. 2025 Sep;100(9):1656-1659. doi: 10.1002/ajh.27734. Epub 2025 Jun 6. Am J Hematol. 2025. PMID: 40478635 No abstract available.
Potential role of the spleen in the development of arterial hypertension in humans.
Nardin M, Agabiti Rosei C, Rossini C, Bertacchini F, Piantoni S, Brami V, Chiarini G, Malerba P, Piacentini N, Sartori S, Ministrini S, Anastasia A, D'Adda M, Porteri E, Airò P, Tiberio GAM, Rossi G, Franceschini F, Rizzoni D, De Ciuceis C. Nardin M, et al. Among authors: d adda m. J Hypertens. 2026 Jan 1;44(1):71-80. doi: 10.1097/HJH.0000000000004115. Epub 2025 Nov 5. J Hypertens. 2026. PMID: 40778682 Free PMC article.
Therapeutic Vaccinations with p210 Peptides in Imatinib-Treated Chronic Myeloid Leukemia Patients: 10 Years Follow-Up of GIMEMA CML0206 and SI0207 Studies.
Sicuranza A, Breccia M, Iuliano F, Gugliotta G, Castagnetti F, Lunghi M, Patriarca A, Intermesoli T, Luciano L, Russo Rossi A, Rege Cambrin G, Vucinic V, Malagola M, Malato A, Abruzzese E, D'Adda M, Galimberti S, Defina M, Sammartano V, Cafarelli C, Cencini E, Cartocci A, Pacelli P, Piciocchi A, Rughini A, Niederwieser D, Bocchia M. Sicuranza A, et al. Among authors: d adda m. Vaccines (Basel). 2025 Apr 16;13(4):419. doi: 10.3390/vaccines13040419. Vaccines (Basel). 2025. PMID: 40333294 Free PMC article.
Second primary malignancies in ruxolitinib-treated myelofibrosis: real-world evidence from 219 consecutive patients.
Maffioli M, Giorgino T, Mora B, Iurlo A, Elli E, Finazzi MC, Caramella M, Rumi E, Carraro MC, Polverelli N, D'Adda M, Malato S, Rossi M, Molteni A, Vismara A, Sissa C, Spina F, Anghilieri M, Cattaneo D, Renso R, Bellini M, Pioltelli ML, Cavalloni C, Barraco D, Accetta R, Bertù L, Della Porta MG, Passamonti F. Maffioli M, et al. Among authors: d adda m. Blood Adv. 2019 Nov 12;3(21):3196-3200. doi: 10.1182/bloodadvances.2019000646. Blood Adv. 2019. PMID: 31698448 Free PMC article.
Direct determination of chronic myeloid leukemia prevalence in Lombardy-Italy: Global implications.
Polverelli N, Anghilieri M, Elena C, Intermesoli T, Pungolino E, D'Adda M, Iurlo A, Maffioli M, Lunghi F, Bertolli V, Orofino N, Sissa C, Fiamenghi C, Gardellini A, Ubezio M, Carraro MC, Corradini P, Giglio F, Pasquini MC, Palazzolo R, Calori R, Ercolanoni M, Gambacorti-Passerini C. Polverelli N, et al. Among authors: d adda m. Hematol Oncol. 2024 Sep;42(5):e3311. doi: 10.1002/hon.3311. Hematol Oncol. 2024. PMID: 39305481
58 results